NewGenIvf Extends Reverse Merger Deadline to Finalize Agreement With EWIHL
NewGenIvf Extends Reverse Merger Deadline to Finalize Agreement With EWIHL
NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today announced that both parties involved in the previously announced reverse merger with European Wellness Investment Holdings Limited ("EWIHL") have appointed legal counsel to prepare the Share Purchase Agreement (the "SPA"). Additionally, by mutual consent, the signing date for the SPA has been extended from January 27, 2025, to February 28, 2025. This extension will allow both parties sufficient time to complete the necessary due diligence, finalize the terms of the agreement, and ensure compliance with all relevant NASDAQ requirements for reverse mergers.
NewgenIVF集团有限公司（纳斯达克股票代码：NIVF）（“NewGen” 或 “公司”）今天宣布，参与先前宣布的与欧洲健康投资控股有限公司（“EWIHL”）的反向合并的双方已指定法律顾问来准备股票购买协议（“SPA”）。此外，经双方同意，最高协议的签署日期已从2025年1月27日延长至2025年2月28日。此次延期将使双方有足够的时间完成必要的尽职调查，最终确定协议条款，并确保遵守纳斯达克对反向合并的所有相关要求。
This significant step follows the Company's prior announcement of a binding term sheet on December 11, 2024, which marked a pivotal moment in the Company's strategic partnership with EWIHL. This collaboration aims to leverage synergies between both companies to enhance service delivery and expand market reach in the healthcare sector.
这一重要举措是在公司先前于2024年12月11日宣布具有约束力的条款表之后迈出的，这标志着公司与EWIHL战略合作伙伴关系的关键时刻。此次合作旨在利用两家公司之间的协同效应，加强服务交付并扩大医疗保健领域的市场覆盖范围。
